ArticleFrontiers in immunology2022
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
Fabrice Cognasse et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2022
this papercites it